U.S. aims to share up to 60 million AstraZeneca vaccine doses with other countries after FDA review
CBSN
The Biden administration is planning to share up to 60 million doses of AstraZeneca's COVID-19 vaccine with other countries, officials confirmed Monday. The decision comes after the White House has faced growing calls to share shots that are likely to otherwise go unused in the United States.
Some 10 million doses manufactured in the U.S. could be shipped out to other countries within the "coming weeks," White House Press Secretary Jen Psaki said Monday. But Psaki noted that the shots first need to clear safety reviews by federal regulators. "Given the strong portfolio of vaccines that the United States has already authorized and that is available in large quantities, including two two-dose vaccines and one one-dose vaccine, and given AstraZeneca is not authorized for use in the United States, we do not need to use AstraZeneca in our fight against COVID over the next few months," Psaki told reporters.Two Native Hawaiian brothers who were convicted in the 1991 killing of a woman visiting Hawaii allege in a federal lawsuit that local police framed them "under immense pressure to solve the high-profile murder" then botched an investigation last year that would have revealed the real killer using advancements in DNA technology.
In one of his first acts after returning to the Oval Office this week, President Trump tasked federal agencies with developing ways to potentially ease prices for U.S. consumers. But experts warn that his administration's crackdown on immigration could both drive up inflation as well as hurt a range of businesses by shrinking the nation's workforce.
Meta is denying claims circulating on social media that it forced Facebook and Instagram users to follow President Trump's official accounts, saying the changes some users noticed were standard practices tied to the transition of the POTUS account from the previous administration to the incoming one.